Showing results (11-20 of 450) with videos related to
Sort By:
Pageof 45
Wiener Klinische Wochenschrift|May 23, 1997
Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patientG Nowak, E Bucha, I Brauns, et al.Hamostaseologie|August 23, 2005
[Ecarin chromogenic assay: an innovative test for quantitative determination of direct thrombin inhibitors in plasma]U Lange, A Olschewski, G Nowak, et al.Thrombosis Research|June 15, 1992
Pharmacology of r-hirudin in renal impairmentG Nowak, E Bucha, T Gööck, et al.Circulatory Shock|October 1, 1992
Favourable effect of defibrotide in lipid A-induced shock in pigsT Hohlfeld, E Bucha, G Nowak, et al.Clinical Nephrology|March 23, 2006
The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parametersK Ulbricht, E Bucha, K A Pöschel, et al.Journal of Pharmaceutical Sciences|May 7, 1999
Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboonsS M Meiring, M G Lötter, P N Badenhorst, et al.Kidney International|December 15, 2000
Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failureK A Pöschel, E Bucha, H U Esslinger, et al.Biology of the Neonate|January 1, 1983
Free thyroid hormone levels during the postnatal period in the pigG NowakPolish Journal of Pharmacology and Pharmacy|March 1, 1989
Lateralization of neocortical dopamine receptors and dopamine level in normal Wistar ratsG NowakHamostaseologie|September 7, 2002
[Rationale for an oral thrombin inhibitor from a pharmacological point of view]G NowakPageof 45